Trial intelligence / Profile preview

Oral melatonin for urinary tract infection in children and adolescents

IRCT20241125063843N1Phase 3Completed

Sponsor
Arak University of Medical Sciences
Start
Nov 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial in urinary tract infection (UTI) comparing Melatonin plus antibiotics with Placebo plus antibiotics (2 arms). Primary endpoints: Fever above 38 degrees Celsius, Dysuria and 3 more. Started Nov 2024; status: completed.

02

Drugs

melatonin
03

Conditions

urinary tract infection (UTI)

Beyond the preview

Go deeper on IRCT20241125063843N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20241125063843N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call